“The Changing Landscape of Mineralocorticoid Receptor Antagonists – Finerenone in Cardiovascular and Renal Health”. 2024. Prospects in Pharmaceutical Sciences 22 (1): 11-15. https://doi.org/10.56782/pps.181.